These guidelines cover the care of patients from the period following kidney transplantation
until the transplant is no longer working or the patient dies. During the early phase …

Cellular blood components and plasma-derived medicinal products (PDMPs) are obtained
from blood donated by volunteers. In a growing number of countries, in line with World …

Results After identifying 2728 studies addressing ABO-incompatible kidney transplantation,
26 studies were included, describing 1346 unique patients who were ABO-incompatible and …

Antibody‐mediated rejection (AMR) is the commonest cause of failure of a pig graft after
transplantation into an immunosuppressed nonhuman primate (NHP). The incidence of …

Mitochondria, known as the powerhouse of the cell, are at the center of healthy physiology
and provide cells with energy in the form of ATP. These unique organelles are also …

No real therapeutic modality is currently available for Acute kidney injury (AKI) and if any,
they are mainly supportive in nature. Therefore, develo** a new therapeutic strategy is …

Background ABO and HLA antibody incompatible (HLAi) renal transplants (AIT) now
comprise around 10% of living donor kidney transplants. However, the relationship between …

Autoimmune thrombotic thrombocytopenic purpura (aTTP) is a severe disease caused by
the production of autoantibodies against von Willebrand factor (vWF)-cleaving ADAMTS13 …

Often the results of randomized controlled trials cannot be confirmed under real-world
conditions [1]. Registry data can provide externally valid long-term comparative …

Background. ABO-incompatible (ABOi) kidney transplantation (KT) expands the kidney
donor pool and may help to overcome organ shortage. Nonetheless, concerns about …